EP3702373
And-PD1 mótefni og notkun þeirra í meðferð og til sjúkdómsgreiningar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.9.2013EP published:
24.8.2022EP application number:
20154386.5
EP translation filed:
26.9.2022Grant published:
15.10.2022EPO information:
European Patent Register
Max expiry date:
12.9.2033Expiry date:
12.9.2026Next due date:
30.9.2026
Title in English:
ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICSLanguage of the patent:
English
Timeline
Today
13.9.2013EP application
24.8.2022EP Publication
26.9.2022Translation submitted
15.10.2022Registration published
12.9.2026Expires
Owner
Name:
BeOne Medicines I GmbHAddress:
Aeschengraben 27, 4051 Basel, CH
Inventor
Name:
SONG, JingAddress:
Changping, Beijing 102206, CN
Name:
LI, KangAddress:
Changping, Beijing 102206, CN
Name:
ZHANG, TongAddress:
Changping, Beijing 102206, CN
Name:
XU, LanlanAddress:
Changping, Beijing 102206, CN
Name:
LIU, QiAddress:
Changping, Beijing 102206, CN
Name:
PENG, HaoAddress:
Changping, Beijing 102206, CN
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Supplementary protection
SPC number:
SPC449
Classification
Categories:
C07K 16/28, A61P 35/00, A61K 39/395, A61P 25/00, A61P 31/12
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 26.9.2022
Expires: 12.9.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 18.8.2023
Expires: 12.9.2024
Payer: Acumass
Number: 12
Paid: 24.9.2024
Expires: 12.9.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 30.9.2025
Expires: 12.9.2026
Payer: Árnason Faktor ehf.